Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older

Published Date:

9/4/12

Language:

English

[PDF-1.28 MB]

Details:

Corporate Authors:

National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.

Description:

Information on cervical cancer screening for women ages 30 and older who have had the Pap and HPV tests. If you have had a Pap test and HPV test, this booklet will answer your questions about: • Cervical cancer • Human papillomavirus (HPV) • Cervical cancer screening tests • What your Pap test result means • What your HPV test result means • What your Pap and HPV test results mean together • How to prevent cervical cancer • Common questions about HPV • How to talk to your partner about your test results • Resources • Glossary of bolded words • Know the facts • Questions to ask your doctor Getting abnormal results does not mean that you have cervical cancer now. For specific questions about your test results, talk to your doctor.

Subject:

[+]

Collection(s):

Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections on a college campus — Duke University, Durham, North Carolina, August 2–October 11, 2020

Personal Author:

Denny, Thomas N.; Andrews, Laura; Bonsignori, Mattia; Cavanaugh, Kyle; Datto, Michael B.; Deckard, Anastasia; DeMarco, C. Todd; DeNaeyer, Nicole; Epling, Carol A.; Gurley, Thaddeus; Haase, Steven B.; Hallberg, Chloe; Harer, John; Kneifel, Charles L.; Lee, Charles L.; Louzao, Raul; Moody, M. Anthony; Moore, Zack; Polage, Christopher R.; Puglin, Jamie; Spotts, P. Hunter; Vaughn, John A.; Wolfe, Cameron R.;

Corporate Authors:

Duke Human Vaccine Institute.. Duke University School of Medicine.. Duke University. Student Affairs.. Duke University School of Medicine. Department of Medicine.. Duke University School of Medicine. Department of Family Medicine.. Duke University of Medicine. Department of Pathology.. Duke University. Office of Information Technology.. Duke University. Emergency Management and Emergency Services.. Duke University. Department of Mathematics.. Duke University School of Medicine. Department of Pediatrics.. North Carolina. Department of Health and Human Services.. Duke University. Office of Assessment..

Published Date:

November 17, 2020

Series:

MMWR. Morbidity and mortality weekly report ; v. 69, early release, November 17, 2020

Description:

What is already known about this topic? SARS-CoV-2 can rapidly spread through university settings. Pooling specimens can enable large-scale testing while minimizing needed resources.What is added by this report? In fall 2020, Duke University’s COVI...

File Type:

[PDF - 208.05 KB]
Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission — United States, March–August 2020

Personal Author:

Lavery, Amy M.; Preston, Leigh Ellyn; Ko, Jean Y.; Chevinsky, Jennifer R.; DeSisto, Carla L.; Pennington, Audrey F.; Kompaniyets, Lyudmyla; Datta, S. Deblina; Click, Eleanor S.; Golden, Thomas; Goodman, Alyson B.; Mac Kenzie, William R.; Boehmer, Tegan K.; Gundlapalli, Adi V.;

Published Date:

November 13 2020

Source:

MMWR Morb Mortal Wkly Rep. 69(45):1695-1699

Description:

Coronavirus disease 2019 (COVID-19) is a complex clinical illness with potential complications that might require ongoing clinical care (1-3). Few studies have investigated discharge patterns and hospital readmissions among large groups of patients a...

File Type:

[PDF - 103.59 KB]
Characteristics of hospitalized COVID-19 patients discharged and experiencing same-hospital readmission — United States, March–August 2020

Personal Author:

Lavery, Amy M.; Preston, Leigh Ellyn; Ko, Jean Y.; Chevinsky, Jennifer R.; DeSisto, Carla L.; Pennington, P Audrey F.; Kompaniyets, Lyudmyla; Datta, S. Deblina; Click, Eleanor S.; Golden, Thomas; Goodman, Alyson B.; Mac Kenzie, William R.; Boehmer, Tegan K.; Gundlapalli, Adi V.;

Corporate Authors:

CDC COVID-19 Response Team.. CDC COVID-19 Response Data, Analytics, and Modeling Task Force..

Published Date:

November 9, 2020

Series:

MMWR. Morbidity and mortality weekly report ; v. 69, early release, November 9, 2020

Description:

What is already known about this topic? Evidence suggests that potential health complications after COVID-19 illness might require ongoing clinical care.What is added by this report? After discharge from an initial COVID-19 hospitalization, 9% of pat...

File Type:

[PDF - 134.90 KB]
Health and Health Determinant Metrics for Cities: A Comparison of County and City-Level Data

Personal Author:

Spoer, Ben R.; Feldman, Justin M.; Gofine, Miriam L.; Levine, Shoshanna E.; Wilson, Allegra R.; Breslin, Samantha B.; Thorpe, Lorna E.; Gourevitch, Marc N.;

Published Date:

November 05 2020

Source:

Prev Chronic Dis. 2020; 17

Description:

We evaluated whether using county-level data to characterize public health measures in cities biases the characterization of city populations. We compared 4 public health and sociodemographic measures in 447 US cities (percent of children living in p...

File Type:

[PDF - 388.86 KB]
Developing a framework for assessing and managing individual-level risk of coronavirus disease 2019 (COVID-19) exposure in mobile populations

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

11/05/2020

Description:

Updated Nov. 5, 2020To provide a framework of considerations for ministries of health and their partners to use while designing and implementing travel-related intervention strategies. The recommendations are based on individual-level risk assessment...

File Type:

[PDF - 275.26 KB]